(Sharecast News) - RUA Life Sciences narrowed its first-half post-tax loss to £203,000 from £635,000, it reported on Tuesday, as revenue rose 6.1% to £2.75m and adjusted EBITDA swung to a £76,000 profit from a £227,000 loss.
The AIM-traded medical device and biomaterials group said gross margin improved to 74.9% from...

Email this article to a friend

or share it with one of these popular networks:

• DIGG
• FACEBOOK
• STUMBLEUPON
• MIXX
• YAHOO BUZZ
• DELICIOUS
• REDDIT
• NEWSVINE